Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common stock, $0.10 par value per share
-
Shares outstanding
-
39,496,021
-
Total 13F shares
-
203,181
-
Share change
-
+57,363
-
Total reported value
-
$167,942
-
Price per share
-
$0.83
-
Number of holders
-
12
-
Value change
-
+$32,229
-
Number of buys
-
9
-
Number of sells
-
3
Institutional Holders of Orthofix Medical Inc. - Common stock, $0.10 par value per share (GROM) as of Q1 2024
As of 31 Mar 2024,
Orthofix Medical Inc. - Common stock, $0.10 par value per share (GROM) was held by
12 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
203,181 shares.
The largest 10 holders included
GEODE CAPITAL MANAGEMENT, LLC, HRT FINANCIAL LP, Virtu Financial LLC, Cubist Systematic Strategies, LLC, Weaver Consulting Group, TWO SIGMA SECURITIES, LLC, Tower Research Capital LLC (TRC), UBS Group AG, MORGAN STANLEY, and Blue Trust, Inc..
This page lists
12
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.